PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 10, 2026Eurosurveillance0 citationsOpen Access

A case of carbapenamase production in Shigella flexneri isolated in Ireland, 2025

View Full Paper
CCChristina ClarkeATAlma TuohyEDErica Duignan

Key Points

  • To report the detection of carbapenemase-producing Shigella flexneri and its implications for treatment.
  • Isolate from a patient in Ireland in October 2025.
  • Carbapenemase detection conducted using lateral flow immunoassay.
  • Characterization included sequencing for sequence type ST245.
  • Detected carbapenemase production in Shigella flexneri with meropenem MIC of 0.12 mg/L.
  • Isolate identified as ST245, related to other sequences but newly linked to bla OXA-181.
  • Findings suggest complications in laboratory detection and treatment protocols.

Abstract

Shigella flexneri producing OXA-181 was detected from a patient in Ireland in October 2025. The isolate had a meropenem minimum inhibitory concentration (MIC) of 0.12 mg/L. Carbapenemase production was detected by lateral flow immunoassay. The sequence type was ST245 and closely related to sequences previously reported from Ireland and other countries but not previously linked to presence of the bla OXA-181 gene . Carbapenemase production in Shigella spp. has implications for laboratory detection and empiric treatment.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Clarke et al. (2026) studied this question.

synapsesocial.com/papers/6a00217ac8f74e3340f9c684https://doi.org/10.2807/1560-7917.es.2026.31.18.2600351
Ask AI
Helpful
Bookmark
Share
View Full Paper